1st IFAPP Science2Business Conference: Academia-Industry Collaboration for New and Better Medicines

IFAPP is proud to announce the 1^st IFAPP Science2Business Conference on ‘academia-industry collaboration for new and better medicines'. This conference, organized by the International Federation of Associations of Pharmaceutical Physicians (IFAPP) will take place on Monday 18^th and Tuesday 19^th of April 2011, in ‘Pakhuis de Zwijger' in Amsterdam.


Introduction
Clinical research forms an essential part in the development of new and better medicines. It does not only pro­duce new knowledge but it also translates into better ways to treat diseases and improve healthcare. Generally there are two types of clinical research, industry-sponsored (industrial) and investigator-initiated (academic) research. Efficient collaboration between industry and academia is essential in conducting high quality clinical trials because of the usually large size of clinical trials requiring many investigators and to ensure all interests are served.


Does the sponsor matter?
The interaction between academia and industry lies at the heart of any drug development process. With con­troversy around these interactions the conference aims to focus on reappraisal of the relationship between industry and academia. How can we define these partnerships whilst respecting the different approach of both stakeholders? The first day of the conference will focus on the value of partnerships in academic-industrial tri­als. The second day will focus on the perspective of journal editors, chief medical officers and the EMA, lead­ing towards increasing publication credibility, thereby paving the road towards trust.


Scientific committee
The members of the scientific committee:

• Rudolf van Olden, MD PhD (GlaxoSmithKline)
• Norbert Clemens, MD PhD (CRS Mannheim GmbH)
• Domenico Criscuolo, MD PhD FFPM (Genovax),
• Prof. Henk-Jan Out, MD PhD (MSD, Radboud University Nijmegen Medical Center)
• Ingrid Klingmann, PhD FFPM (EFGCP)
• Prof. Silvio Garattini, MD PhD (ECRIN)
• Prof. Dick de Zeeuw, MD PhD (DCTF, University Medical Center Groningen)

Key topics include

• How to manage conflicts of interest?
• Best practices for academic-industrial relations
• Partners in research
• Pharmaceutical Medicine
• Safety reporting
• Collaboration models
• Conflicts of interest in scientific journals
• Recommendations for trustworthy partnerships

Brochure-1st-IFAPP-Science2Business-Conference-10022011.pdf